Therefore, the DNA methylation of the SHOX2 gene has been qualified as a sensitive biomarker for lung cancer diagnosis and staging, specifically for SCC and SCLC [14, 15, 17, 39], accompanied by an analysis of the methylation level of PTGER4 in our study. Here, PTGER4 is linked to lung carcinoma.